Re: “Too old masters’ age group”… I have zero insight as to whether or not this will happen, but I’m a betting man & I’m putting my money on yes. If CrossFit lasts, which I think it will, I believe they’ll continue to evolve as the sport grows in size and age. It’ll come down to how many “too old” athletes end up being serious competitors. You’ll lead the way.
The best part of CFA are the people! CrossFit has really changed my life and my perspective on so much. There are so many things that CrossFit and it’s community of people, especially the women, have taught me. I’ve finally found not only an outlet I was missing since my gymnastics days, but also a group of people who continually inspire me, support me and others, and are genuinely interested in seeing their peers meet goals. CrossFit has completely solidified my viewpoint that people and relationships matter most in life.
Alcohol is a no-no if you are strict paleo. Beer is made from grains, and liquor also contains traces of gluten. But, good news for cider-lovers: most hard ciders are gluten-free, so they are allowed. Check the label to be sure. Red wine is more accepted in the paleo community because it contains the antioxidant resveratrol, but sorry chardonnay lovers, white wine is technically not allowed.
For immediate weight loss, Paleo is a great and healthy solution. But after carefully reading and considering, I’m unconvinced that Paleo is optimal for long-term health. I think, in fact, it might lead to heart disease and other ills associated with heavy meat consumption. Although many of Cordain’s theories fall apart long-term, I thoroughly enjoyed the read and highly recommend the book. You should read critically and decide for yourself.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”